Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,526 public trials 2,840 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants of Any Age With Acute Myeloid Leukemia

NCT04813263

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Anjou Kousei Hospital /ID# 244213 Anjo-shi, Aichi-ken, Japan
  • Nagoya City West Medical Center /ID# 250844 Nagoya, Aichi-ken, Japan
  • Aichi Cancer Center Hospital /ID# 243785 Nagoya, Aichi-ken, Japan
  • Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital /ID# 242173 Nagoya, Aichi-ken, Japan
View all 281 locations
View Trial Details
Completed

A Study of JNJ-68284528 Out-of-Specification (OOS) for Commercial Release in Participants With Multiple Myeloma

NCT05347485

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • City of Hope Duarte, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
View all 18 locations
View Trial Details
Completed

A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma

NCT01998971

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Duarte, California, United States
  • Atlanta, Georgia, United States
  • Chicago, Illinois, United States
  • Indianapolis, Indiana, United States
View all 22 locations
View Trial Details
Completed

A Randomized Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP Pts

NCT05583838

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • The Second Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China
  • the Second Hospital of HeBei Medical University Shijiazhuang, Hebei, China
  • North China University of Science and Technology Affiliated Hospital Tangshan, Heibei, China
  • The Second Affiliated Hospital of Harbin Medical University Harbin, Heilongjiang, China
View all 17 locations
View Trial Details
Completed

TJ202 Combined With Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

NCT03860038

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Beijing Chao-Yang Hospital,Capital medical university Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Nanfang Hospital of SMU Guangzhou, Guandong, China
View all 18 locations
View Trial Details

Related conditions